Status | Study |
Not yet recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer Condition: Major Salivary Gland Carcinoma Minor Salivary Gland Carcinoma Date: 2017-05-05 Interventions: Biological: Ipilimumab Given I |
Recruiting |
Study Name: Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors Condition: Salivary Gland Tumors Head and Neck Cancer Date: 2016-09-30 Interventions: Drug: Docetaxel Docetaxel only |
Recruiting |
Study Name: Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers Condition: Salivary Glands Tumors Date: 2016-08-11 Interventions: Drug: Abiraterone acetate Abiraterone acetate is a prodrug of abiraterone, an irreversible inhibitor of |
Recruiting |
Study Name: Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors Condition: Salivary Gland Tumors Head and Neck Cancer Date: 2016-05-12 Interventions: Drug: Cisplatin Cisplatin 80mg |
Recruiting |
Study Name: Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 Condition: Salivary Gland Cancers Date: 2016-05-06 Interventions: Drug: Axitinib Axitinib will be self orally administered at 5 mg twice daily approximately every 12 hour |
Active, not recruiting |
Study Name: Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck Condition: Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck Date: 2015-09-22 Interventions: Drug: BIBF1120 Nintedanib will be given orally at a dose of 200mg twice daily (bid) until progression or |
Active, not recruiting |
Study Name: Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma Condition: Salivary Gland Carcinoma Date: 2015-03-13 Interventions: Drug: pazopanib treatment will be given until progression or unacceptable toxicity . |
Recruiting |
Study Name: A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes Condition: Salivary Gland Cancer Metastatic Advanced Date: 2014-02-20 Interventions: Drug: Selinexor Other Name: KP |
Recruiting |
Study Name: Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer Condition: Salivary Gland Cancer Date: 2014-01-23 Interventions: Radiation: brachytherapy Radiation: IMRT |
Recruiting |
Study Name: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer Condition: Salivary Gland Cancer Date: 2013-09-24 Interventions: Drug: bicalutamide + triptorelin Drug: Cis |